Clinical trials
Gaucher Disease trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lysosomal and Rare Disorders Research and Treatment Center, Inc. | 5 |
| O & O Alpan LLC | 2 |
| Assiut University | 1 |
| Brigham and Women's Hospital | 1 |
| CANbridge (Suzhou) Bio-pharma Co., Ltd. | 1 |
| Fairview University Medical Center | 1 |
| M.A.G.I.C. Clinic LTD | 1 |
| Mansoura University Children Hospital | 1 |
| National Center for Research Resources (NCRR) | 1 |
| National Taiwan University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gaucher Disease | 22 |
| Fabry Disease | 4 |
| Glycogen Storage Disease Type II | 4 |
| Lysosomal Storage Diseases | 4 |
| Niemann-Pick Diseases | 3 |
| Metabolic Diseases | 2 |
| Metabolism, Inborn Errors | 2 |
| Parkinson Disease | 2 |
| Rare Diseases | 2 |
| Sphingolipidoses | 2 |
Trials
Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.